Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$18,053.92
% of Total Estimate Gain
3.22%

MFS Prudent Investor Fund's Bio-Rad Laboratories Inc Holding Summary

As of 2024-12-31, MFS SERIES TRUST XVI held - shares of Bio-Rad Laboratories Inc(BIO), totaling N/A. This investment constitutes 0% of their stock portfolio, and MFS SERIES TRUST XVI now holds 0% of the outstanding Bio-Rad Laboratories Inc(BIO) stock.

The initial trade took place in 2023Q4. And since then MFS Prudent Investor Fund has made 2 purchases of BIO, at an average price of $313.54, for a total of 1,790.00 shares. In addition, there have been 2 sales at an average price of $323.63 for 1,790.00 shares. Based on historical transaction data and BIO's current price of $235.54, MFS Prudent Investor Fund's estimated gain on his BIO holdings is $18,053.92, reflecting a 3.22% gain to date.

MFS Prudent Investor Fund BIO ($235.54) Holding Chart

MFS Prudent Investor Fund BIO ($235.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1